ArticleBMC health services research2023
One-year healthcare costs after robotic-assisted and laparoscopic partial and radical nephrectomy: a cohort study.
Article in BMC health services research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Robot-assisted and embolization-assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal angiomyolipoma: a systematic review and meta-analysis.Journal of robotic surgery · 2025Pooled it
- Global research trends and thematic evolution in robot-assisted radical nephrectomy: a bibliometric and visualisation study.Journal of robotic surgery · 2026Article
- Development and Validation of a Nomogram for Predicting Postoperative Deep Vein Thrombosis Risk in Patients After Laparoscopic Partial Nephrectomy.Cancer management and research · 2026Article
- QUIPS-based prospective postoperative pain assessment following nephrectomy and partial nephrectomy in robot-assisted, conventional laparoscopic, and open surgical approaches.Frontiers in surgery · 2026Article
- Comparing R.E.N.A.L., PADUA, and RPN Scores: Is RPN the More Logical Choice in the Robotic Era?BJU international · 2025Review
- Review
- Review
- Health Service Use and Costs During Pregnancy Among Privately Insured Individuals With Congenital Heart Disease.JAMA network open · 2024Article
- Design and utilisation of a novel, high-fidelity, low-cost, hybrid-tissue simulation model to facilitate training in robot-assisted partial nephrectomy.Journal of robotic surgery · 2024Article
- Time trends in surgical provision and cancer-specific outcomes in patients with stage T2-3 kidney cancer: a SEER-based study.Frontiers in surgery · 2024Article
- Robotic-assisted partial nephrectomy outcomes with airseal® versus conventional insufflation: A single tertiary center comparative study.Therapeutic advances in urologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDespite the wide-spread adoption of robotic-assisted surgery (RAS), the cost-benefit implications for partial (PN) and radical nephrectomy (RN) versus laparoscopic surgery (Lap) is not well established. We sought to examine the trend of adoption and 1-year healthcare expenditure of PN and RN, and compare 1-year expenditures of RAS versus Lap for PN and RN. PATIENTS AND
methodsThis cohort study used the Merative
resultsAdoption of PN increased overtime (47.0% to 55.8%), mainly driven by robotic PN increase. Among PN, RAS had lower open-conversion, shorter LOS and lower index expenditure than Lap. Among RN, RAS had shorter LOS, and similar open-conversion and index expenditures. During 1-year post-discharge, RAS had lower hospital outpatient visits (IRR = 0.92, 95% CI = 0.85, 0.99, p = 0.029) and office-based visits (IRR = 0.91, 95% CI = 0.86, 0.96, p = 0.002) for PN, translating to a 1-day less (95% CI = 0.25, 1.75, p = 0.008) missed from work for RAS. Following RN, RAS had lower 1-year readmission than Lap (O.R = 0.72, 95% CI = 0.55, 0.94, p = 0.018). RAS and Lap had comparable 1-year post-discharge expenditures for both PN (mean difference, MD = -$475, 95% CI = -$4362, $3412, p = 0.810) and RN (MD = -$4,204, 95% CI = -$13,837, $5430, p = 0.404).
conclusionAt index surgery, RAS was associated with shorter LOS for both PN and RN, and lower open-conversion and expenditures for PN. RAS and Lap had comparable 1-year total expenditures, despite lower healthcare visits for RAS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.